Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.

Sánchez-Vega F, Gotea V, Petrykowska HM, Margolin G, Krivak TC, DeLoia JA, Bell DW, Elnitski L.

Epigenetics. 2013 Dec;8(12):1355-72. doi: 10.4161/epi.26701. Epub 2013 Oct 22.

2.

Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study.

Tian CQ, Darcy KM, Krivak TC, Deloia JA, Armstrong D, Davis W, Zhao H, Moysich K, Ambrosone CB.

Front Oncol. 2013 Aug 12;3:206. doi: 10.3389/fonc.2013.00206. eCollection 2013.

3.

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.

Lesnock JL, Darcy KM, Tian C, Deloia JA, Thrall MM, Zahn C, Armstrong DK, Birrer MJ, Krivak TC.

Br J Cancer. 2013 Apr 2;108(6):1231-7. doi: 10.1038/bjc.2013.70. Epub 2013 Mar 5.

4.

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.

Abkevich V, Timms KM, Hennessy BT, Potter J, Carey MS, Meyer LA, Smith-McCune K, Broaddus R, Lu KH, Chen J, Tran TV, Williams D, Iliev D, Jammulapati S, FitzGerald LM, Krivak T, DeLoia JA, Gutin A, Mills GB, Lanchbury JS.

Br J Cancer. 2012 Nov 6;107(10):1776-82. doi: 10.1038/bjc.2012.451. Epub 2012 Oct 9.

5.

Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.

Deloia JA, Bhagwat NR, Darcy KM, Strange M, Tian C, Nuttall K, Krivak TC, Niedernhofer LJ.

Gynecol Oncol. 2012 Sep;126(3):448-54. doi: 10.1016/j.ygyno.2012.05.006. Epub 2012 May 16.

6.

BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.

Dann RB, DeLoia JA, Timms KM, Zorn KK, Potter J, Flake DD 2nd, Lanchbury JS, Krivak TC.

Gynecol Oncol. 2012 Jun;125(3):677-82. doi: 10.1016/j.ygyno.2012.03.006. Epub 2012 Mar 8.

PMID:
22406760
7.

Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.

Kolbe DL, DeLoia JA, Porter-Gill P, Strange M, Petrykowska HM, Guirguis A, Krivak TC, Brody LC, Elnitski L.

PLoS One. 2012;7(3):e32941. doi: 10.1371/journal.pone.0032941. Epub 2012 Mar 5.

8.

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.

Rubatt JM, Darcy KM, Tian C, Muggia F, Dhir R, Armstrong DK, Bookman MA, Niedernhofer LJ, Deloia J, Birrer M, Krivak TC.

Gynecol Oncol. 2012 May;125(2):421-6. doi: 10.1016/j.ygyno.2012.01.008. Epub 2012 Jan 16.

9.

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.

Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA.

Gynecol Oncol. 2012 Mar;124(3):575-81. doi: 10.1016/j.ygyno.2011.11.022. Epub 2011 Nov 21.

10.

Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.

Richard SD, Bencherif B, Edwards RP, Elishaev E, Krivak TC, Mountz JM, DeLoia JA.

Nucl Med Biol. 2011 May;38(4):485-91. doi: 10.1016/j.nucmedbio.2010.12.003. Epub 2011 Mar 3.

PMID:
21531285
11.

Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study.

Krivak TC, Darcy KM, Tian C, Bookman M, Gallion H, Ambrosone CB, Deloia JA.

Gynecol Oncol. 2011 Jul;122(1):121-6. doi: 10.1016/j.ygyno.2011.03.027. Epub 2011 Apr 14.

PMID:
21496891
12.

Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer.

Zamboni WC, Combest AJ, DeLoia JA, Edwards RP, Bridges AS, Zamboni BA, Walko CM, Yu AY, Krivak TC, Kelley JL.

Cancer Chemother Pharmacol. 2011 Nov;68(5):1255-62. doi: 10.1007/s00280-011-1609-9. Epub 2011 Mar 25.

PMID:
21437702
13.

Cigarette exposure induces changes in maternal vascular function in a pregnant mouse model.

Gandley RE, Jeyabalan A, Desai K, McGonigal S, Rohland J, DeLoia JA.

Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1249-56. doi: 10.1152/ajpregu.00274.2009. Epub 2010 Feb 17.

14.

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer.

Krivak TC, Darcy KM, Tian C, Armstrong D, Baysal BE, Gallion H, Ambrosone CB, DeLoia JA; Gynecologic Oncology Group Phase III Trial.

J Clin Oncol. 2008 Jul 20;26(21):3598-606. doi: 10.1200/JCO.2008.16.1323.

15.

Comparison of cell cycle regulatory gene mRNA in three different types of human trophoblasts and effect of transforming growth factor.

Richard CA, Jones JM, DeLoia JA.

J Obstet Gynaecol Res. 2008 Apr;34(2):152-61. doi: 10.1111/j.1447-0756.2008.00753.x.

PMID:
18412775
16.

Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.

Guirguis A, Elishaev E, Oh SH, Tseng GC, Zorn K, DeLoia JA.

Gynecol Oncol. 2008 Feb;108(2):370-6.

PMID:
18083218
17.
19.

Expression and activity of taxane-metabolizing enzymes in ovarian tumors.

DeLoia JA, Zamboni WC, Jones JM, Strychor S, Kelley JL, Gallion HH.

Gynecol Oncol. 2008 Feb;108(2):355-60. Epub 2007 Dec 11.

PMID:
18063021
20.

Tumorigenic epithelial stem cells and their normal counterparts.

Donnenberg VS, Luketich JD, Landreneau RJ, DeLoia JA, Basse P, Donnenberg AD.

Ernst Schering Found Symp Proc. 2006;(5):245-63. Review.

PMID:
17939305
21.

Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.

Thrall MM, DeLoia JA, Gallion H, Avril N.

Gynecol Oncol. 2007 Apr;105(1):17-22. Epub 2007 Jan 10.

PMID:
17208284
22.

The effects of cigarette smoking on circulating maternal leukocytes during pregnancy.

Luppi P, Lain KY, Jeyabalan A, DeLoia JA.

Clin Immunol. 2007 Feb;122(2):214-9. Epub 2006 Dec 11.

PMID:
17161974
23.

Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway.

Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA.

Am J Reprod Immunol. 2006 Aug;56(2):135-44.

PMID:
16836616
24.

BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study.

Thrall M, Gallion HH, Kryscio R, Kapali M, Armstrong DK, DeLoia JA.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:166-71.

PMID:
16515585
25.

Intracellular adhesion molecule concentrations in women who smoke during pregnancy.

Lain KY, Luppi P, McGonigal S, Roberts JM, DeLoia JA.

Obstet Gynecol. 2006 Mar;107(3):588-94.

PMID:
16507929
26.

Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines.

Luppi P, Deloia JA.

Clin Immunol. 2006 Feb-Mar;118(2-3):268-75. Epub 2005 Dec 5.

PMID:
16337193
27.

Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression.

Peters DG, Kudla DM, Deloia JA, Chu TJ, Fairfull L, Edwards RP, Ferrell RE.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1717-23.

28.

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

Wilcox CB, Baysal BE, Gallion HH, Strange MA, DeLoia JA.

Cancer Genet Cytogenet. 2005 Jun;159(2):114-22.

PMID:
15899382
29.

CD11b Expression on circulating leukocytes increases in preparation for parturition.

Luppi P, Irwin TE, Simhan H, Deloia JA.

Am J Reprod Immunol. 2004 Nov;52(5):323-9.

PMID:
15550069
30.

Centrosome abnormalities in ovarian cancer.

Hsu LC, Kapali M, DeLoia JA, Gallion HH.

Int J Cancer. 2005 Feb 20;113(5):746-51.

31.

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH.

Gynecol Oncol. 2004 Oct;95(1):62-9.

PMID:
15385111
32.

Monocytes are progressively activated in the circulation of pregnant women.

Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA.

J Leukoc Biol. 2002 Nov;72(5):874-84.

PMID:
12429709
33.

Normal pregnancy is associated with peripheral leukocyte activation.

Luppi P, Haluszczak C, Trucco M, Deloia JA.

Am J Reprod Immunol. 2002 Feb;47(2):72-81.

PMID:
11900591
34.

Effects of exogenous estrogen on uterine leukocyte recruitment.

DeLoia JA, Stewart-Akers AM, Brekosky J, Kubik CJ.

Fertil Steril. 2002 Mar;77(3):548-54.

PMID:
11872211
35.

Physiological range of human chorionic gonadotropin for support of early human pregnancy.

Richard CA, Kubik CJ, DeLoia JA.

Fertil Steril. 2001 Nov;76(5):988-93.

PMID:
11704122
36.

Placental cellular immune response in women infected with human parvovirus B19 during pregnancy.

Jordan JA, Huff D, DeLoia JA.

Clin Diagn Lab Immunol. 2001 Mar;8(2):288-92.

37.

Stimulation of uterine cell cytokine production by ovarian hormones.

DeLoia JA, Stewart-Akers AM, Brekosky J, Kubik C.

Am J Reprod Immunol. 2000 Jul;44(1):16-21.

PMID:
10976808
38.

Evidence for superantigen involvement in preeclampsia.

Luppi P, McKnight C, Mathie T, Faas S, Rudert WA, Stewart-Akers AM, Trucco M, DeLoia JA.

Am J Reprod Immunol. 2000 Apr;43(4):187-96.

PMID:
10836246
40.

Globoside expression within the human placenta.

Jordan JA, DeLoia JA.

Placenta. 1999 Jan;20(1):103-8.

PMID:
9950151
41.

Regional specialization of the cell membrane-associated, polymorphic mucin (MUC1) in human uterine epithelia.

DeLoia JA, Krasnow JS, Brekosky J, Babaknia A, Julian J, Carson DD.

Hum Reprod. 1998 Oct;13(1O):2902-9.

PMID:
9804253
42.

Methotrexate effects on trophoblast and the corpus luteum in early pregnancy.

Creinin MD, Stewart-Akers AM, DeLoia JA.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):604-9.

PMID:
9757959
43.

Effects of methotrexate on trophoblast proliferation and local immune responses.

DeLoia JA, Stewart-Akers AM, Creinin MD.

Hum Reprod. 1998 Apr;13(4):1063-9.

PMID:
9619571
44.

Endometrial leukocytes are altered numerically and functionally in women with implantation defects.

Stewart-Akers AM, Krasnow JS, Brekosky J, DeLoia JA.

Am J Reprod Immunol. 1998 Jan;39(1):1-11.

PMID:
9458927
45.

Decidual leukocyte populations in ectopic pregnancies.

Stewart-Akers AM, Krasnow JS, DeLoia JA.

Fertil Steril. 1997 Dec;68(6):1103-7.

PMID:
9418705
46.

Expression of beta-adrenergic receptor kinase subtypes in the pregnant rat myometrium.

Ruzycky AL, DeLoia JA.

Am J Obstet Gynecol. 1997 May;176(5):1077-83.

PMID:
9166171
47.

Differential expression of G1 cyclins during human placentogenesis.

DeLoia JA, Burlingame JM, Krasnow JS.

Placenta. 1997 Jan;18(1):9-16.

PMID:
9032805
48.

Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy.

Krasnow JS, Tollerud DJ, Naus G, DeLoia JA.

Hum Reprod. 1996 Aug;11(8):1747-54.

PMID:
8921127
49.

The mouse cyclin E maps to chromosome 7.

Johnson DK, Stubbs LJ, DeLoia JA.

Mamm Genome. 1996 Mar;7(3):245. No abstract available.

PMID:
8833259
50.

Molecular cloning and characterization of murine cyclin E.

Damjanov I, Shan J, Wang RF, Damjanov A, DeLoia JA.

Biochem Biophys Res Commun. 1994 Jun 15;201(2):994-1000.

PMID:
8003041

Supplemental Content

Loading ...
Support Center